If you’ve noticed stubborn dark spots, age patches, or uneven skin tone —
whether on your face, hands, or neck — you know how frustrating they can be.



<[link removed]>

October 17


 



Hands, Face, Neck — Here’s How to Even Out Skin Tone

Try This →
<[link removed]>






If you’ve noticed stubborn dark spots, age patches, or uneven skin tone —
whether on your face, hands, or neck — you know how frustrating they can be.

They don’t just fade on their own… and in many cases, they seem to get more
noticeable as time goes by.

<[link removed]>
Sure, there are plenty of products claiming to make them disappear — but many
useharsh bleaching agents that can irritate and damage your skin over time.

After treating countless patients dealing with skin concerns, a leading skin
health expert developed a completely different approach — one that doesn’t rely
on bleach or abrasive chemicals.

Instead, this simple, at-home method is designed to help support a smoother,
more even-looking complexion.

See the Simple Dark Spot-Fading Method Here
<[link removed]>
Thousands have already tried it — and the before-and-after results speak for
themselves.*
*All individuals are unique. Results can and will vary.


If you no longer wish to get these emails, you can unsubscribe by clicking
here.
<[link removed]>


 





Health Briefing · The Hill Report
A 2020 Law Moved Hydroquinone Creams Behind an Approval Gate
Hydroquinone skin-lightening products lost their over-the-counter footing when
Congress rewrote the monograph system, and the Food and Drug Administration's
later warning letters, mercury test table and the way dermatology names dark
spots show how that gate now works. Connor Hill · InsightfulWord · October 17
Key points

Red flags come first: the American Academy of Dermatology says to see a
dermatologistimmediately for a spot that is asymmetric, irregular,
multicolored, larger than a pencil eraser or changing; swelling of the face or
throat after a product is an emergency.

Since the CARES Act became law on March 27, 2020, over-the-counter skin
lightening products containing hydroquinone have been deemed new drugs that
need an approved application.

On April 19, 2022, the Food and Drug Administration (FDA) sent warning letters
to12 companies and cited reports of skin rashes, facial swelling and ochronosis.

FDA's consumer warning, current as of Aug 24, 2026, lists 30 tested products,
with mercury as high as27,762 parts per million.
Dark spots on the face, hands and neck are described in two vocabularies.
Regulators describe the products sold for them by ingredient and legal status.
Dermatologists describe the spots themselves by cause and by depth in the skin.

This week's news touched both. A journal digest on Wednesday summarized a
study of online skin products, some marketed for hyperpigmentation, that held a
prescription-strength steroid not named on the label. Regulators abroad,
meanwhile, kept adding imported lightening creams to mercury advisories.

On the tape
Oct 14Dermatology Times' journal digest summarized a JAMA Network Open study,
published Oct 8, finding that 6 of 18 online skin products marketed for
conditions including eczema, psoriasis and hyperpigmentation contained
undeclared clobetasol propionate, the highest at more than 9 times the 0.05%
approved strengthWhy it matters: The digest notes that undisclosed steroid
exposure may itself cause dyspigmentation, so a label and a jar's contents can
diverge.
Oct 16A check of FDA press announcements from Oct 1 to Oct 16 found none on
skin lightening, mercury or hydroquinoneWhy it matters: The most recent federal
word remains the agency's August consumer warning and its test table.
Oct 12Managed Healthcare Executive reported an Oct 9 Fall Clinical Dermatology
Conference talk in which an Emory study was cited: about 33 patients examined
per skin cancer found, and 181 among those 50 or youngerWhy it matters:
Screening is moving toward risk, which places more weight on a person noticing
a spot that changes.
Oct 7The EcoWaste Coalition in the Philippines welcomed Philippine Food and
Drug Administration advisories posted Oct 3 and 5 on three unauthorized
lightening creams; its own screening found mercury up to 27,270 ppmWhy it
matters: The ASEAN cosmetic limit cited is 1 ppm, the same yardstick used in
U.S. coverage.
Aug 24FDA updated its warning on skin products containing mercury and/or
hydroquinone, adding 8 products tested in 2026 to a table that now holds 30Why
it matters: The table, not a press release, is where the agency's lab results
are posted.
Before anything else
The American Academy of Dermatology advises seeing a dermatologist immediately
if a mole or pigmented spot shows any ABCDE sign: Asymmetry, an irregular
Border, varied Color, a Diameter usually above 6 millimeters, or Evolving size,
shape or color. It also advises an appointment for spots that are new, itch or
bleed; a sore that does not heal deserves the same look. Swelling of the face,
lips or throat, or difficulty breathing, after applying any product is a reason
to call 911. No prescribed medication should be started, stopped or changed
except with the prescriber.


How a Monograph Rewrite Reached a Cream Jar
For decades, many over-the-counter drugs were sold under monographs, rulebooks
listing allowed ingredients, strengths and label wording. A product that
followed one needed no individual approval.

The CARES Act, Public Law 116-136, signed March 27, 2020, added section 505G
to the Federal Food, Drug, and Cosmetic Act and converted that system into
administrative orders. Hydroquinone skin lighteners did not carry over. FDA
states that since enactment, such products "are deemed to be new drugs and are
misbranded."

The agency set a date. Effective Sept 23, 2020, makers and distributors of
over-the-counter skin lightening products without FDA approval were to remove
them from the market.

Enforcement followed on April 19, 2022. FDA issued warning letters to 12
companies selling hydroquinone products without a prescription and asked each
to respond within 15 days. It also added certain manufacturers to an import
alert to keep their products out of the country.

FDA also said it had received reports of serious side effects, including skin
rashes, facial swelling and ochronosis, a blue-black discoloration it says may
be permanent.

Hydroquinone itself remains in medicine. FDA identifies a single approved drug
containing it, a prescription combination cream for short-term treatment of
dark spots tied to moderate to severe melasma of the face, to be used under the
supervision of a licensed health care professional.

By the numbers
March 27, 2020CARES Act enacted, reforming the over-the-counter monograph
system
Sept 23, 2020Date FDA set for unapproved over-the-counter skin lighteners to
leave the market
12Companies sent FDA warning letters over hydroquinone products on April 19,
2022
15 daysTime FDA gave those companies to respond
1FDA-approved drug containing hydroquinone, a prescription cream for facial
melasma
30Products in FDA's mercury and hydroquinone test table, covering 2019, 2022
and 2026

Mercury Travels in Imported Jars
Hydroquinone is one concern; mercury is the other. FDA says it "does not allow
mercury in drugs or in cosmetics, except under very specific conditions," and
that the lightening products it tested do not meet them.

The agency's table, current as of Aug 24, 2026, lists 7 products tested in
2019, 15 in 2022 and 8 in 2026. Mercury readings run from 47 ppm to 27,762 ppm.
Five of the 2022 products also contained hydroquinone, at 1.2% to 4.4%.

FDA describes the harm in terms of absorption. Repeated application can let
mercury enter the bloodstream, with risks that include kidney damage and nerve
effects such as tremors, tingling, numbness, headaches, fatigue and changes in
mood or thinking. The agency says risk rises with longer and more frequent use,
and names children and pregnant people as facing greater risk.

An older FDA consumer page lists label words that signal mercury: "mercurous
chloride," "calomel," "mercuric," "mercurio" and "mercury." It advises against
any product with no label.

The Philippine advisories this month, and the 1 ppm ASEAN limit cited
alongside them, describe the same supply chains from the other end.

🧴 Pigment Signal27,762 ppm
That is the highest mercury reading in FDA's current test table, recorded in a
whitening cream tested in 2026. Against the 1 ppm limit cited in Southeast
Asian cosmetic rules, it is more than 27,000 times higher. The reading is a
laboratory result for one product, not a measure of what reaches the
bloodstream. FDA's description of risk turns on repetition: the longer and more
often a mercury-bearing cream is applied, the greater the potential harm.


Three Kinds of Dark Spot, Described Three Ways
Dermatology does not treat dark spots as one condition. Three common patterns
carry different names and associations.

Solar lentigines, often called age spots or liver spots, are described by
Harvard Health Publishing as collections of pigment caused by sun exposure.
They commonly appear on the hands and other sun-exposed areas, are most common
after 55 and are described as not harmful.

Melasma is described by the National Library of Medicine's StatPearls review,
updated Jan 31, 2026, as symmetric brown-to-gray patches with irregular
borders, mainly on sun-exposed facial skin. Series show a marked predominance
in women, and Fitzpatrick skin types III to V are disproportionately affected.

The review links melasma onset or worsening to ultraviolet and visible light,
pregnancy and outside estrogen or progesterone. It cautions that these are
associations, and that causality cannot be inferred from cross-sectional data.
Historically, a Wood lamp sorted melasma as epidermal, dermal or mixed; the
review now calls those findings inconsistent in darker skin.

Postinflammatory hyperpigmentation, in a StatPearls entry updated Nov 25,
2024, follows skin inflammation or injury such as acne, eczema, burns or peels.
It is more common and more severe in darker skin. Pigment held in the outer
layers looks brown, while pigment that reaches the dermis looks blue-gray and
lasts longer.

The melasma review adds one more entry to the list of look-alikes: exogenous
ochronosis, a paradoxical blue-black pigmentation seen with long-term
hydroquinone exposure. The same word appears in FDA's 2022 letters.

Where a dark spot is described
American Academy of DermatologyABCDE warning signs for a pigmented spotAbout 6
mm, the size of a pencil eraser
Harvard Health PublishingSolar lentigo, or age spot, from sun exposureMost
common after 55
StatPearls, MelasmaSymmetric facial patches, associations with light and
hormonesUpdated Jan 31, 2026
StatPearls, Postinflammatory HyperpigmentationPigment after inflammation,
brown versus blue-grayUpdated Nov 25, 2024
One question for the desk
When a cream sold for dark spots lists its ingredients, does the label make
clear whether it is regulated as a drug or a cosmetic?

Hit reply — one line is enough.

Worth stating plainly
The 2020 CARES Act reform left hydroquinone skin lighteners outside the
over-the-counter rulebook, and FDA set Sept 23, 2020, as the date for
unapproved products to leave the market. Warning letters to 12 companies
followed in 2022, citing rashes, facial swelling and ochronosis. FDA's test
table now lists 30 products with mercury readings as high as 27,762 ppm.
Dermatology separates age spots, melasma and postinflammatory
hyperpigmentation, and factors tied to melasma are associations rather than
proven causes. A changing, irregular or bleeding spot is a reason for a
dermatologist's look.

The short checklist
1.Treat a new, changing, irregular, multicolored, bleeding or non-healing spot
as a reason to see a dermatologist.
2.Treat swelling of the face or throat, or trouble breathing, after any
product as an emergency.
3.Look for mercurous chloride, calomel, mercuric, mercurio or mercury on a
label, and set aside products with no label.
4.Check whether a product sold without a prescription lists hydroquinone as an
ingredient.
5.Note which of the three spot types a clinician names, since each has
different associations.
6.Keep medication decisions with the prescriber.


Replies to this briefing reach a person, not a queue.

Connor Hill reads every reply.

Sources checked Verified October 16, 2026 Food and Drug Administration, FDA
works to protect consumers from potentially harmful OTC skin lightening
products, April 19, 2022; press announcements page, checked Oct 16, 2026 Food
and Drug Administration, FDA Warns Consumers of Skin Products Containing
Mercury and/or Hydroquinone, content current as of Aug 24, 2026; consumer
update, Mercury Poisoning Linked to Skin Products Food and Drug Administration,
Final Administrative Order OTC000028 under section 505G, citing CARES Act
enactment of March 27, 2020 Dermatology Times, Journal Digest, Oct 14, 2026;
Managed Healthcare Executive, report on the Fall Clinical Dermatology
Conference, Oct 12, 2026 Pressenza, EcoWaste Coalition release on Philippine
FDA advisories, Oct 7, 2026; American Academy of Dermatology, What to look for:
ABCDEs of melanoma National Library of Medicine StatPearls, Melasma, updated
Jan 31, 2026, and Postinflammatory Hyperpigmentation, updated Nov 25, 2024;
Harvard Health Publishing, Age spots (solar lentigo, liver spots) Connor Hill
writes The Hill Report for InsightfulWord, a daily briefing on the machinery
behind the numbers.



Insightful Word (IW) is a daily publication of TerraTrance Technologies, LLC.



We'd love to hear from you. Reply to this email with any question, or write to
us [email protected] <mailto:[email protected]>



TerraTrance Technologies, LLC. This email may not be reproduced or distributed
without prior written consent.

200 Broadway Blvd NE, Albuquerque, NM 87102

Privacy Policy <[link removed]>
Terms & Conditions <[link removed]>
Unsubscribe
<[link removed]>



© 2026 Insightful Word (IW) · Thank you for reading.